Invention Grant
US08476283B2 [6,5]—bicyclic GPR119 G protein-coupled receptor agonists
有权
[6,5] - 双环GPR119 G蛋白偶联受体激动剂
![[6,5]—bicyclic GPR119 G protein-coupled receptor agonists](/docs/US/2013-07-02/US08476283B2/abs.jpg.600x600.jpg)
- Patent Title: [6,5]—bicyclic GPR119 G protein-coupled receptor agonists
- Patent Title (中): [6,5] - 双环GPR119 G蛋白偶联受体激动剂
-
Application No.: US13307698Application Date: 2011-11-30
-
Publication No.: US08476283B2Publication Date: 2013-07-02
- Inventor: John M. Fevig , Dean A. Wacker
- Applicant: John M. Fevig , Dean A. Wacker
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Terence J. Bogie
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A61K31/519 ; C07D487/00
![[6,5]—bicyclic GPR119 G protein-coupled receptor agonists](/abs-image/US/2013/07/02/US08476283B2/abs.jpg.150x150.jpg)
Abstract:
Novel compounds are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. These novel compounds have the structure: or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein n2, n3, n4, A, B, D, E, G, J, Y, R1 and R2 are defined herein.
Public/Granted literature
- US20120077826A1 [6,5] - BICYCLIC GPR119 G PROTEIN-COUPLED RECEPTOR AGONISTS Public/Granted day:2012-03-29
Information query
IPC分类:
